Penumbra Operating Income Growth & History (PEN)
Penumbra's operating income was $189.2M for fiscal 2025.
View full Penumbra company overviewPenumbra annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $189.2M | $180.0M | +1939.54% |
| 2024 | 2024-12-31 | $9.3M | −$64.3M | −87.38% |
| 2023 | 2023-12-31 | $73.6M | $67.5M | +1109.32% |
| 2022 | 2022-12-31 | $6.1M | $13.6M | — |
| 2021 | 2021-12-31 | −$7.5M | $31.4M | — |
| 2020 | 2020-12-31 | −$38.9M | −$86.5M | — |
| 2019 | 2019-12-31 | $47.5M | $48.4M | — |
| 2018 | 2018-12-31 | −$852,000 | −$2.0M | — |
| 2017 | 2017-12-31 | $1.2M | $2.5M | — |
| 2016 | 2016-12-31 | −$1.4M | −$5.5M | — |
| 2015 | 2015-12-31 | $4.2M | $1.2M | +38.88% |
| 2014 | 2014-12-31 | $3.0M | $4.1M | — |
| 2013 | 2013-12-31 | −$1.1M | — | — |
Penumbra quarterly operating income
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $41.0M | $211,000 | +0.52% |
| Q1 2026 | 2026-03-31 | $38.2M | −$2.1M | −5.24% |
| Q4 2025 | 2025-12-31 | $59.2M | $16.5M | +38.48% |
| Q3 2025 | 2025-09-30 | $48.8M | $13.5M | +38.10% |
| Q2 2025 | 2025-06-30 | $40.8M | $121.8M | — |
| Q1 2025 | 2025-03-31 | $40.4M | $28.2M | +233.44% |
| Q4 2024 | 2024-12-31 | $42.8M | $7.7M | +22.11% |
| Q3 2024 | 2024-09-30 | $35.4M | $22.7M | +180.11% |
| Q2 2024 | 2024-06-30 | −$81.0M | −$98.8M | — |
| Q1 2024 | 2024-03-31 | $12.1M | $4.1M | +51.11% |
| Q4 2023 | 2023-12-31 | $35.0M | $30.2M | +624.79% |
| Q3 2023 | 2023-09-30 | $12.6M | $7.2M | +132.33% |
| Q2 2023 | 2023-06-30 | $17.9M | $18.0M | — |
| Q1 2023 | 2023-03-31 | $8.0M | $12.1M | — |
| Q4 2022 | 2022-12-31 | $4.8M | $44.9M | — |
| Q3 2022 | 2022-09-30 | $5.4M | −$3.3M | −38.12% |
| Q2 2022 | 2022-06-30 | −$139,000 | −$10.5M | — |
| Q1 2022 | 2022-03-31 | −$4.0M | −$17.5M | — |
| Q4 2021 | 2021-12-31 | −$40.1M | −$38.3M | — |
| Q3 2021 | 2021-09-30 | $8.8M | $28.9M | — |
| Q2 2021 | 2021-06-30 | $10.3M | $28.0M | — |
| Q1 2021 | 2021-03-31 | $13.5M | $12.9M | +2107.05% |
| Q4 2020 | 2020-12-31 | −$1.7M | −$12.3M | — |
| Q3 2020 | 2020-09-30 | −$20.2M | −$33.1M | — |
| Q2 2020 | 2020-06-30 | −$17.6M | −$30.4M | — |
| Q1 2020 | 2020-03-31 | $610,000 | −$10.5M | −94.53% |
| Q4 2019 | 2019-12-31 | $10.6M | $3.9M | +58.63% |
| Q3 2019 | 2019-09-30 | $13.0M | $33.8M | — |
| Q2 2019 | 2019-06-30 | $12.8M | $3.5M | +37.90% |
| Q1 2019 | 2019-03-31 | $11.2M | $7.1M | +175.70% |
| Q4 2018 | 2018-12-31 | $6.7M | $2.8M | +72.95% |
| Q3 2018 | 2018-09-30 | −$20.8M | −$21.5M | — |
| Q2 2018 | 2018-06-30 | $9.3M | $10.6M | — |
| Q1 2018 | 2018-03-31 | $4.0M | $6.1M | — |
| Q4 2017 | 2017-12-31 | $3.9M | $5.0M | — |
| Q3 2017 | 2017-09-30 | $683,000 | $2.0M | — |
| Q2 2017 | 2017-06-30 | −$1.3M | −$658,000 | — |
| Q1 2017 | 2017-03-31 | −$2.0M | −$3.9M | — |
| Q4 2016 | 2016-12-31 | −$1.2M | −$3.0M | — |
| Q3 2016 | 2016-09-30 | −$1.4M | −$3.5M | — |
| Q2 2016 | 2016-06-30 | −$670,000 | $3.1M | — |
| Q1 2016 | 2016-03-31 | $1.8M | −$2.2M | −54.01% |
| Q4 2015 | 2015-12-31 | $1.8M | — | — |
| Q3 2015 | 2015-09-30 | $2.2M | $1.9M | +601.61% |
| Q2 2015 | 2015-06-30 | −$3.8M | — | — |
| Q1 2015 | 2015-03-31 | $4.0M | — | — |
| Q3 2014 | 2014-09-30 | $311,000 | — | — |
Penumbra operating income trends
Over the last five fiscal years, Penumbra's operating income increased from −$38.9M to $189.2M, a change of $228.2M. The latest reported quarter, Q2 2026, shows $41.0M.
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Penumbra source filings ↗Community posts
Penumbra’s thrombectomy business leads 16% quarterly sales growth
Penumbra ($PEN) reported third-quarter 2026 revenue of $410.1 million, up 15.6%, as demand for its clot-removal systems expanded. Thrombectomy sales increased 18.1% to $279.2 million, including 26% growth in the US venous-thromboembolism bu ...